Zhaoke Ophthalmology's Application for Children's Myopia Drug Accepted in Australia
Zhaoke Ophthalmology's (HKG:6622) registration application for Atropine Sulfate Eye Drops was accepted for evaluation by the Therapeutic Goods Administration of Australia, according to a Monday Hong Kong bourse filing.The drug is for slowing the progression of myopia in children.